Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on February 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Modification to Extend Services for Scientific, Operations and Administrative Resources (SOAR) Contract Program

Closed
OLAO-SSD-SOAR-NOIFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institutes of Health, through the National Institute on Drug Abuse, is executing a non-competitive extension of the Scientific, Operations, and Administrative Resources (SOAR) contract program to ensure uninterrupted support for critical biomedical research activities. The SOAR program consists of five indefinite-delivery, indefinite-quantity contracts held by Axle Informatics LLC, Gap Solutions, Inc., Kelly Services, Inc., Guidehouse Digital LLC, and 22nd Century Technologies, Inc., with a combined maximum ordering value of $3.6 billion. The current ordering period is set to expire on June 21, 2026, but this amendment extends the base ordering period by twelve months to June 21, 2027, and adds two optional six-month extensions extending through June 21, 2028. Crucially, the clause governing task order duration is being revised to permit task orders to extend up to thirty-six months beyond the conclusion of the full extended ordering period, providing necessary flexibility for a phased transition to a future competitive procurement. This extension does not increase the contract ceiling; the remaining available funds of approximately $2.17 billion will be used to fulfill new and existing task orders under the revised timeframe. The extension is justified under FAR 6.103-1 due to the uniquely specialized and highly technical nature of the services, which require deep institutional knowledge, scientifically fluent personnel such as bioinformaticists, molecular biologists, and clinical research coordinators, and seamless continuity to protect ongoing research investments, prevent disruption to NIH’s mission, and avoid costly and risky transitions. Only the incumbent contractors possess the necessary expertise and infrastructure to deliver these services without jeopardizing the integrity of active biomedical projects, benchmark studies, and translational science efforts. The effort is part of a broader HHS initiative to consolidate and refine professional service procurements and is intended as a temporary measure to allow sufficient time for a full and open competition to be planned, executed, and transitioned without operational interruption. Responses to this presolicitation are solicited through March 5, 2027, to assess potential alternatives, but award will proceed non-competitively unless compelling evidence demonstrates viable competition exists. All proposers must hold an active SAM registration, provide their Unique Entity Identifier, and certify their business size status, with submissions required via email to designated NIH points of contact.

General Info

NIH extends SOAR contract through June 2028 with optional extensions, maintaining $3.6B ceiling for specialized biomedical support.

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

541690 - Other Scientific and Technical Consulting ServicesView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(1)

Amendment 1 to OLAO-SSD-SOAR-NOI Notice of Intent

PDF1 pageamendment

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts2 people available
OfficeBethesda, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Nida
View Agency Profile
Office AddressBethesda, MD, 20892, USA
Contacts

Full Description

Show more

Amendment 1
This presolicitation notice of proposed acquisition is posted as an intent to negotiate and award Modifications to Extend Services for Scientific, Operations and Administrative Resources (SOAR) Contract Program on a non-competitive basis.



The purpose of this acquisition is to acquire a variety of task order services under the NIH Scientific, Operations, and Administrative Resources (SOAR) Support Services contract program; and this Class Justification for other than full and open competition (JOFOC) is to extend services under this program to allow sufficient time to recompete and transition services.



The SOAR contract program includes five (5) indefinite-delivery, indefinite-quantity (IDIQ) contracts: 75N95021D00010, 75N95021D00011, 75N95021D00012, 75N95021D00013, and 75N95021D00019, with the contract holders listed in the table below.



AXLE INFORMATICS LLC


6116 EXECUTIVE BOULEVARD SUITE 400


NORTH BETHESDA, MD 20852-4931


75N95021D00010



GAP SOLUTIONS, INC.


205 VAN BUREN STREET, SUITE 205


HERNDON, VA 20170-5348


75N95021D00011



KELLY SERVICES, INC


999 WEST BIG BEAVER ROAD


TROY, MI 48084-4716


 75N95021D00012



GUIDEHOUSE DIGITAL LLC


1676 INTERNATIONAL DRIVE, SUITE 800


MCLEAN, VA 22102


 75N95021D00013



22ND CENTURY TECHNOLOGIES, INC.


8251 GREENSBORO DRIVE SUITE 900


MCLEAN, VA 22102-4938


75N95021D00019




The SOAR contracts have a combined maximum contract ordering value of $3,600,713,546. Currently, the ordering period ends June 21, 2026, and task orders may extend up to twelve (12) months past the parent contract ordering period end, through June 20, 2027.



The purpose of this JOFOC is: (1) to extend the parent IDIQ ordering period by twelve (12) months and incorporate two six-month optional ordering period extensions; and (2) to revise FAR 52.216-22 to incorporate language to allow the period that task orders may extend past the extended IDIQ parent contract ordering period end and option extensions, if exercised, from twelve (12) months up to thirty-six (36) months.



Basic ordering period extension: June 22, 2026 – June 21, 2027 (12 months)


Optional ordering period extension 1: June 22, 2027 – December 21, 2027 (6 months)


Optional ordering period extension 2: December 22, 2027 – June 21, 2028 (6 months)



The current combined IDIQ maximum contract ordering value of $3,600,713,546 remains unchanged. This JOFOC does not increase the contract ordering value. The Estimated Total Dollar Value for Orders through end of the JOFOC Extension is $2,174,615,674, which is the remaining available value, as of January 8, 2026, under the original contract maximum value of $3,600,713,546 (unchanged).



The Government projects award of the contract extension modifications in April 2026, and subsequent task orders using fiscal year 2026 and future year funds with annual and variable types of funding being used.



Description of Supplies and/or Services:  



Under the SOAR contract program, contractors provide specialized scientific professional services from qualified and experienced contractor staff to support the NIH in meeting its operational objectives. The scientific professional services provide a full range of activities, including new and in-progress research projects, program deployment and implementation, and other activities necessary to conduct the business and fulfill the mission of NIH’s biomedical research program. Services support important medical discoveries that improve people’s health, prevent disease, and investigate the causes, treatments, and cures for common and rare diseases.



Task orders under the current SOAR contract currently provide specialized scientific services to all 29 NIH organizations, including the Office of the Director, the 27 Institutes and Centers (ICs), and the Advanced Research Projects Agency for Health (ARPA-H). Task order requirements are processed in accordance with FAR 16.507. It is a technically complex and high throughput requirement that necessitates the contractor to have scientifically fluent and robust management resources to recruit and manage an ample pool of highly specialized labor categories (e.g., Bioinformatics Scientists, Statisticians, Molecular Biologists, Clinical Research Coordinators, and Registered Nurses) in a fast-paced environment.



Planning for the follow-on requirement for SOAR ramped up at the start of fiscal year (FY) 2024. During FY24 and early FY25, the National Institute on Drug Abuse (NIDA) OA conducted market research, held industry days, collaborated with HHS Office of Small Disadvantaged Business Utilization, formed an Integrated Project Team with HHS stakeholders, and began developing requirements for the follow-on SOAR contract.



In the second quarter of FY25, HHS initiated a comprehensive procurement consolidation effort to eliminate waste and duplication in compliance with Executive Order "Eliminating Waste and Saving Taxpayer Dollars by Consolidating Procurement." As part of this initiative, HHS and NIH are conducting a thorough review of the SOAR follow-on contract requirements alongside HHS's broader professional service needs to identify the optimal procurement strategy for essential services.


To maintain continuity of operations while these strategic acquisition plans are finalized, NIH requires a contract extension for SOAR. This extension will provide sufficient time and resources to conduct a competitive acquisition process appropriate to the scope and scale of these requirements and will enable a seamless transition from the current contract vehicle to future procurement mechanism(s).



Statutory Authority Cited and Rationale:



RFO - FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. Authority: 41 U.S.C. 3304(a)(1). Per RFO - HHSAR 306.103-1, for acquisitions covered by 42 U.S.C. 247d-6a(b)(2)(A), “available from only one responsible source” must be deemed to mean “available from only one responsible source or only from a limited number of responsible sources.”



The NIH has an ongoing critical need for scientific professional services under the SOAR contract program and requires an extension to the ordering period and period for task order services. Only the current contract-holders under this multiple-award contract program can provide the task order services required at the level of quality required because the supplies or services ordered are unique or highly specialized.



The current contract-holders are uniquely qualified to seamlessly provide these specialized services for the extended ordering period, without disruption to the programs, while the larger follow-on acquisition is competed. If NIH were to compete and award new contracts to any other contractor, it would be inefficient, disrupt research services, incur more costs, and negatively impact ongoing NIH programs and biomedical research.



Specifically, the loss of these services would jeopardize NIH’s ability to maintain up-to-date compliant policies and delegations of authority, creates the loss of critical benchmark studies, and impacts NIH’s ability to protect current and past investments in research. Furthermore, it will negatively impact NIH’s ability to fulfill essential responsibilities, directly impacting patient diagnostics and treatments. This will cause scientific staff to re-prioritize and adjust their scientific research pursuits to manage these functions, as well as additional costs to provide required training. Additionally, loss of these services will result in delays and other negative potential impacts, such as compromising scientific productivity, delaying critical milestones, and jeopardizing the return on existing investments in ongoing research efforts focused on advancing the mission of NIH. Without the requested services, both clinical and translational science would be severely disrupted, and in some cases, cease to progress. In conclusion, if the services under this task order are interrupted or do not continue, it would lead to a disruption in essential research activities, a loss of investment in the studies, wasted research funds, and potential delays in critical scientific advancements. The financial and reputational impacts would be significant, and the research may not reach its intended outcomes, ultimately affecting the mission of HHS to advance scientific knowledge and improve public health. Extending the ordering period and task order services period under the current SOAR contracts efficiently allows continuity of critical tasks necessary for advancing the scientific goals of the NIH while ensuring continuity and integrity of the ongoing biomedical research programs.



Special Considerations:



HHS and NIH are in the process of defining their needs and finalizing strategic plans for a competitive follow-on requirement(s), and the extensions to the SOAR contract is an interim solution to ensure continuity of services. The 12-month ordering period extension is the minimum time needed for HHS and NIH to finalize its strategy, re-procure, and transition the services. The two 6-month ordering period extensions are included as options to allow for unknown contingencies. The revision to allow new orders to extend up to 36 months past the end of the extended ordering period and options, if exercised, will provide the OA with the flexibility necessary to transition orders to the new vehicles in an organized and phased approach.



It would be neither cost effective nor realistic to expect another contractor to perform these specialized services during the interim period, considering the start-up costs, phase-in, transfer of Government furnished property, recruitment and staffing requirements. Instead, the Government intends to allow time for the follow-on requirement(s) to be fairly competed, properly evaluated, and successfully awarded.



In the interim, the current contract-holders are uniquely positioned to meet NIH’s wide-ranging needs with minimal staffing disruptions and without compromising ongoing research. Attempting to transition these requirements to new vendors for such a short duration would be highly inefficient, likely resulting in widespread service disruptions and jeopardizing millions of dollars in active and completed research efforts. NIH is the primary Federal agency for conducting and supporting medical research and is helping to lead the way toward important medical discoveries that improve people’s health. NIH scientists rely on these services in their endeavor to investigate ways to prevent disease, as well as the causes, treatments, and cures for common and rare diseases that have a direct effect on American citizens and the global population.



The contract period extensions are the minimum acceptable and necessary to meet mission requirements. Additionally, this extension of services does not exceed the time necessary for the agency to award another contract program(s) for the required services using competitive procedures.



Procurement History:



Current Multiple Award IDIQ Contract Holders: (1) Axle Informatics LLC, (2) Gap Solutions, Inc. , (3) Kelly Services, Inc., (4) Guidehouse Digital LLC, and (5) 22nd Century Technologies, Inc.


Contract or Order Numbers: 75N95021D00010, 75N95021D00011, 75N95021D00012, 75N95021D00013, 75N95021D00019


Award Date and Period of Performance: April 19, and July 6, 2021; with ordering period of July 8, 2021-June 21, 2026


Value (including all options): $3,600,713,546


Competitive Status: Competitive


Authority formerly relied upon if Not Competed: N/A



Summary Statement:


This is a notice of intent to negotiate and award contract modifications to extend services under the existing SOAR contracts, on a non-competitive basis, on or about March 6, 2026.



This is not a request for competitive proposals, and the Government is not committed to award a contract action pursuant to this announcement. However, interested parties may identify their interest and capability to respond to this notice.



A determination by the Government not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement for this extension period.
 


Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Unique Entity Identifier Number (UEIN)), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.www.sam.gov.
 


All responses to this pre-solicitation notice must be received by 5:00 PM Eastern Standard Time, on March 5, 2026 and must reference the announcement number specified above. 
 


Responses may be submitted electronically to Robin Knightly (Robin.Knightly@nih.gov) and Kyle Miller (Kyle.Miller2@nih.gov)
 


Fax responses will not be accepted.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541715
New
Federal
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
Solicitation # 75N98026R00144SB
This Small Business Sources Sought notice is issued by the National Institutes of Health to identify qualified small business sources capable of providing comprehensive medicinal chemistry services for the Medicinal Chemistry Support Program for Therapeutic Development. The government seeks a turn-key operation to support preclinical drug discovery efforts, including exploratory, hit-to-lead, and lead optimization phases. Required capabilities include SAR analysis and design, synthesis, in vitro ADMET studies, computational chemistry, and compound logistics. Vendors must demonstrate the capacity to manage one to ten concurrent projects and possess the necessary technical personnel and facilities to scale operations as needed. Interested small businesses under NAICS code 541715 must submit detailed responses by September 14, 2026, addressing their in-house capabilities, professional experience, and staffing qualifications. The government is using this notice to determine if the requirement can be set aside exclusively for small businesses and to evaluate whether the services should be classified as commercial or research and development. Responses should be emailed to the designated points of contact and must include the organization's Unique Entity Identifier and small business status. This notice is for research purposes only and is not a formal solicitation for proposals.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 26 days
View Details
NAICS: 541715
New
Federal
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
Solicitation # 75N98026R00144
This Sources Sought notice is issued by the National Institutes of Health to identify qualified vendors capable of providing comprehensive medicinal chemistry services for the Medicinal Chemistry Support Program for Therapeutic Development. The government is seeking a full-service, turn-key operation to support preclinical drug discovery efforts, including exploratory, hit-to-lead, and lead optimization phases. Required capabilities include SAR analysis and design, synthesis, in vitro ADMET studies, computational chemistry, and compound logistics. Vendors must demonstrate the ability to manage between one and ten concurrent projects and provide detailed information regarding their staffing, facilities, and experience in advancing compounds toward Phase 1 clinical testing. The primary objective of this notice is to conduct market research to determine the availability of qualified sources and assess whether the requirement can be set aside for small businesses under NAICS code 541715. The government has preliminarily determined that these services are not commercial in nature, though vendors are encouraged to provide evidence if they believe the services are commercial. Interested parties must submit a detailed response by September 14, 2026, including their Unique Entity Identifier and business size status. This is not a solicitation for proposals, and the government is not responsible for any costs incurred during the response process.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 26 days
View Details